Publicacions en què col·labora amb José Javier Aristu Mendioroz (15)

2012

  1. The multimodal management of locally advanced N2 non-small cell lung cancer: Is there a role for surgical resection? A single institution's experience

    Clinical and Translational Oncology, Vol. 14, Núm. 11, pp. 835-841

2009

  1. Role of surgery in a multidisciplinary approach to superior sulcus tumors (SST): Morbidity and prognostic factors for long-term success after resection

    Thoracic and Cardiovascular Surgeon, Vol. 57, Núm. 6, pp. 353-357

2008

  1. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation

    Radiotherapy and Oncology, Vol. 88, Núm. 3, pp. 342-350

2007

  1. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 9, pp. 596-602

2005

  1. Initial results of a prospective clinical study of cisplatin/paclitaxelbased hyperfiractionated chemoradiation (3DCRTHF) in squamous cell head and neck cancer (HNC) stages III-IV

    EJC SUPPLEMENTS

  2. Radiation pneumonitis following combined modality therapy in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC) including three-dimensional conformal radiation therapy (3D-CRT):: analysis of clinical and dosimetric prognostic factors

    EJC SUPPLEMENTS

  3. Three-dimensional conformal radiation therapy (3D-CRT) in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC):: Influence of clinical and dosimetric parameters on patterns of failure and survival

    EJC SUPPLEMENTS

  4. Three-dimensional conformal radiation therapy (3D-CRT) in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC):: Influence of clinical and dosimetric parameters on patterns of failure and survival

    EJC SUPPLEMENTS

2004

  1. Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 27, Núm. 3, pp. 299-303

  2. Preliminary experience with intensity modulated radiation therapy for abdominopelvic tumor sites: a comparison with 3D radiotherapy plans

    Revista de oncología: Publicación oficial de la Federación de Sociedades Españolas de Oncología y del Instituto Nacional de Cancerología de México, Vol. 6, Núm. 7, pp. 415-423

2003

  1. Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer

    Oncology, Vol. 64, Núm. 1, pp. 28-35

2002

  1. Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, Núm. 4, pp. 347-353

2001

  1. Effect of PSA nadir and the time to nadir in the disease-free period in localized prostatic carcinoma treated with radical radiation

    Revista de medicina de la Universidad de Navarra, Vol. 45, Núm. 1, pp. 20-28

2000

  1. Carcinoma de nasofaringe localmente avanzado: Resultados finales del tratamiento de quimiorradioterapia seguido de quimioterapia complementaria

    Clinical and Translational Oncology, Vol. 2, Núm. 6, pp. 301-308

1999

  1. Induction platinum-based chemotherapy followed by radical hyperfractionated radiotherapy with concurrent chemotherapy in the treatment of locally advanced non-small-cell carcinoma of the lung

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 22, Núm. 2, pp. 203-208